Cargando…
Clinical Utility of Comprehensive Genomic Profiling in Patients with Unresectable Hepatocellular Carcinoma
SIMPLE SUMMARY: This study aimed to investigate the clinical usefulness of comprehensive genomic profiling (CGP) in patients with unresectable hepatocellular carcinoma who received multiple systemic therapies in real-world practice. In this study, all nine patients had gene alterations, and seven we...
Autores principales: | Ishido, Shun, Tsuchiya, Kaoru, Kano, Yoshihito, Yasui, Yutaka, Takaura, Kenta, Uchihara, Naoki, Suzuki, Keito, Tanaka, Yuki, Miyamoto, Haruka, Yamada, Michiko, Matsumoto, Hiroaki, Nobusawa, Tsubasa, Keitoku, Taisei, Tanaka, Shohei, Maeyashiki, Chiaki, Tamaki, Nobuharu, Takahashi, Yuka, Nakanishi, Hiroyuki, Sakurai, Urara, Asahina, Yasuhiro, Okamoto, Ryuichi, Kurosaki, Masayuki, Izumi, Namiki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913078/ https://www.ncbi.nlm.nih.gov/pubmed/36765676 http://dx.doi.org/10.3390/cancers15030719 |
Ejemplares similares
-
Clinical Usefulness of Monitoring Muscle Volume during Atezolizumab Plus Bevacizumab Therapy in Patients with Unresectable Hepatocellular Carcinoma
por: Matsumoto, Hiroaki, et al.
Publicado: (2022) -
Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
por: Ishido, Shun, et al.
Publicado: (2023) -
Switching from entecavir to tenofovir alafenamide for maintaining complete virological response in chronic hepatitis B
por: Ishido, Shun, et al.
Publicado: (2023) -
Pemigatinib treatment for intrahepatic cholangiocarcinoma with FGFR2 fusion detected by a liquid comprehensive genomic profiling test
por: Ishido, Shun, et al.
Publicado: (2023) -
Clinical evaluation of Elecsys PIVKA-II for patients with advanced hepatocellular carcinoma
por: Kaneko, Shun, et al.
Publicado: (2022)